Vktx nasdaq.

Jul 10, 2023 · Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ... NASDAQ: VKTX · IEX Real-Time Price · USD. Add to Watchlist 12.02-0.26 (-2.16%) Nov 27, 2023, 12:50 PM EST - Market open. Overview; Financials; ... Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for VKTX stock stock is $29.36, which predicts an increase of 144.36%. The lowest target is …Shares of Viking Therapeutics (NASDAQ: VKTX) are trading down over 15% late into Tuesday's session, in a move linked to the disappointing clinical data posted by VKTX's competitor Altimmune, Inc ...Back to VKTX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

VKTX News. This page features the latest news about the Viking Therapeutics Inc stock. ... Which NASDAQ companies generate more than $100 billion a year?Find the latest SEC Filings data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis.

Clinical-stage biotech Viking Therapeutics ( VKTX 6.23%) is having another tough trading session. As of 1:40 p.m. ET Tuesday, Viking's stock was down by 19.8% on higher-than-normal volume ...

VKTX Overview Stock Screener Earnings Calendar Sectors Nasdaq | VKTX U.S.: Nasdaq Viking Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 20, 2023 7:59...SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...(NASDAQ: VKTX) Viking Therapeutics's market cap is $978.28M, as of Nov 12, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Viking Therapeutics 's market cap is calculated by multiplying VKTX 's current stock price of $9.78 by VKTX 's total outstanding shares of 100,028,953 .Rhumbline Advisers acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to its most recent …

Viking Therapeutics (VKTX 4.42%), a small-cap biotech, has been on quite the ride over the past few months.Thanks to a positive late-stage trial in nonalcoholic steatohepatitis (NASH) from rival ...

Fintel reports that on May 3, 2023, Roth MKM maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 31.63% Upside. As of April 24 ...

Find the latest Madrigal Pharmaceuticals, Inc. (MDGL) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Viking Therapeutics, Inc VKTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... NASDAQ data is at least 15 minutes delayed.In trading on Tuesday, shares of Viking Therapeutics Inc (Symbol: VKTX) entered into oversold territory, hitting an RSI reading of 25.3, after changing hands as low as $15.06 per share. By ...Nasdaq Composite Stock Market Premium Services. Stock Advisor. Our Flagship Service. Return. ... VKTX. $12.01 (-2.24%) $0.28 *Average returns of all recommendations since inception. Cost basis and ...("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today ...

Viking Therapeutics, Inc. Common Stock (VKTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today ...Novavax Stock Is Going to Recover, Says 5-Star Analyst. After a disastrous 2022 impacted by underwhelming sales of its Covid-19 vaccine NVX-CoV2373, which saw the shares lose a brutal 93% of their ...Apr 4, 2023 · Find out why VKTX stock is a Buy. ... (NASDAQ:VKTX). As you know, Viking shares recently rallied over 60% in a single trading session due to its positive early obesity data. Though Viking executed ... Viking Therapeutics (NASDAQ:VKTX) spiked in late December, due to recent news indirectly related to the biopharma firm, and its efforts to bring a treatment for non-alcoholic steatohepatitis (or ...As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ...Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript (Insider Monkey) Feb-08-23 04:05PM Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update (PR Newswire) Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the …

NASDAQ: $115: $15 - $17 7,187,500: Goldman Sachs Cowen & Company: Preclinical biotech developing kinase inhibitors for cancer and genetic diseases. CoLucid Pharmaceuticals Burlington, MA: CLCD ...In trading on Tuesday, shares of Viking Therapeutics Inc (Symbol: VKTX) entered into oversold territory, hitting an RSI reading of 25.3, after changing hands as low as $15.06 per share. By ...

Oct 25, 2023 · Viking Therapeutics Inc ( NASDAQ:VKTX) reported a strong quarter-end cash position of $376M. The company's net loss for Q3 2023 was $22.5 million, or $0.23 per share, compared to a net loss of $15 ... Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.16 may 2023 ... On the stock market today, VKTX stock surged 12.1% to close at 24.64. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ...If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company.Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP agonist compound VK2735 for the ...View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...

Market Cap. $1.3B. Currency in USD. Quote data delayed by at least 15 minutes.

See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Viking Therapeutics, Inc.'s stock symbol is VKTX and currently trades under NASDAQ. It's current price per share is approximately $15.30. When is Viking ...Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.3,698,369. 784,592. 4.713748. Back to VKTX Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid ...VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 83% based on the firm’s underlying fundamentals and the stock ...MSFT. Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Viking Therapeutics, Inc. Common Stock (VKTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ...Jul 10, 2023 · Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ... VKTX data by YCharts. Which low-priced healthcare stocks might be the next big movers? Wall Street analysts think Agenus ( AGEN 1.60% ) and Aclaris Therapeutics ( ACRS 3.01% ) could deliver market ...VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.Viking Therapeutics' (NASDAQ:VKTX) shares rose 14% after clinical results from a Phase 1 trial on its obesity drug, VK2735, were released. The study showed that VK2735, a dual agonist of GLP-1 and ...

According to the issued ratings of 9 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 9 buy ratings for VKTX. The average twelve-month price prediction for Viking Therapeutics is $30.25 with a high price target of $37.00 and a low price target of $19.00.Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share.All thanks to its potential treatment for obesity, VK2735. So far, we know it works ...The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ...VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...Instagram:https://instagram. intel's earningsupcoming ex dividend dates 2023leading gainers todayus broker forex Viking Therapeutics, Inc (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today ...16 may 2023 ... On the stock market today, VKTX stock surged 12.1% to close at 24.64. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ... dominoes stockdiversified reits NASDAQ: VKTX Viking Therapeutics. Market Cap. $1B. Today's Change (1.85%) $0.21. Current Price. $11.56. ... (VKTX 1.85%) are down about 25% from the peak they reached in mid-March. If you weren't ... sp500 outlook Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing treatments for liver diseases, post surgical complications, and other ailments. Despite a hefty short interest percentage, the firm's shares ...Viking Therapeutics, Inc.'s stock symbol is VKTX and currently trades under NASDAQ. It's current price per share is approximately $15.30. When is Viking ...Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.